Higher Cardiorespiratory Fitness Protects Men Against Many Cancers
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Aug. 17, 2023 -- Higher cardiorespiratory fitness protects men against many site-specific cancers, according to a study published online Aug. 15 in the British Journal of Sports Medicine.
Aron Onerup, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues examined associations between cardiorespiratory fitness and incidence of site-specific cancer using data from 1.078 million men who underwent military conscription (1968 to 2005) with a mean follow-up of 33 years.
The researchers found that higher cardiorespiratory fitness was linearly associated with a lower risk for developing cancer in the head and neck (hazard ratio [HR], 0.81), esophagus (HR, 0.61), stomach (HR, 0.79), pancreas (HR, 0.88), liver (HR, 0.60), colon (HR, 0.82), kidney (HR, 0.80), and lung (HR, 0.58). Higher cardiorespiratory fitness was associated with higher risk for being diagnosed with prostate cancer (HR, 1.07) and malignant skin cancer (HR, 1.31).
"Our study suggests that cardiorespiratory fitness is linearly associated with a lower hazard of developing most of the site-specific cancers assessed here, some of which have not previously been reported in relation to cardiorespiratory fitness or physical activity," the authors write. "These results strengthen the incentive for promoting interventions aimed at increasing cardiorespiratory fitness in youth."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
ASCO: Germline Variation Does Not Predict Taxane-Induced Peripheral Neuropathy
FRIDAY, June 7, 2024 -- Germline variation does not predict the risk of taxane-induced peripheral neuropathy (TIPN) in Black women receiving paclitaxel (once weekly) or docetaxel...
Neoadjuvant Nivolumab, Ipilimumab Safe for dMMR Colon Cancer
WEDNESDAY, June 5, 2024 -- Neoadjuvant nivolumab plus ipilimumab has an acceptable safety profile in patients with locally advanced mismatch repair-deficient (dMMR) colon cancer...
Lowering FIT Positivity Thresholds Improves Sensitivity, Specificity
WEDNESDAY, June 5, 2024 -- Lowering the fecal immunochemical test (FIT) positive threshold yields levels of sensitivity and specificity that are comparable to those reported for...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.